Addex Therapeutics Ltd / Fundamentals
Income statement
- Net revenue
€184.86K - Cost of goods sold
€0.00 - Gross profit
€184.86K - SG&A expenses
€1.68M - R&D expenses
€312.74K - EBITDA
-€5.91M - D&A
€207.89K - EBIT
-€2.79M - Interest expenses
€3.77K - EBT
-€6.12M - Tax expenses
€0.00 - Net income
€9.39M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€11.95M - Changes in working capital
-€1.87M - Operating cash flow
-€4.09M - Capex
€1.38K - Other investing cash flow
€5.03M - Net investing cash flow
€5.03M - Total cash dividends paid
€0.00 - Issuance of common stock
€113.16K - Debt repayment
-€9.47K - Other financing cash flow
-€62.12K - Net financing cash flow
€41.56K - Foreign exchange effects
-€15.00K - Net change in cash
€1.30M - Cash at end of period
€3.06M - Free cash flow
-€4.09M
Balance sheet
- Cash and cash equivalents
€3.06M - Cash and short-term investments
€3.07M - Total receivables
€38.31K - Inventory
€0.00 - Other current assets
€357.10K - Total current assets
€3.46M - Property, plant & equipment
€43.98K - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€6.76M - Other non-current assets
€7.69K - Total non-current assets
€6.81M - Total assets
€10.28M - Accounts payable
€310.01K - Short-term debt
€8.02K - Other current liabilities
€812.59K - Total current liabilities
€1.14M - Long-term debt
€35.54K - Deferred tax liabilities
€0.00 - Other non-current liabilities
€107.65K - Total non-current liabilities
€143.19K - Total liabilities
€1.29M - Common stock
€2.00M - Retained earnings
-€384.44M - Other equity
€33.75M - Total equity
€8.99M - Total liabilities and shareholders' equity
€10.28M
Company information
- Market capitalization
€11.68M - Employees
2 - Enterprise Value
€8.66M
Company ratios
- Gross margin
-
100.0% Much better than peer group: 19.5% - EBITDA margin
-
-3,195.2% Much worse than peer group: -1,228.7% - EBIT margin
-
-1,508.2% Much worse than peer group: -1,363.8% - EBT margin
-
-3,309.7% Much worse than peer group: -1,357.4% - Net margin
-
5,081.4% Much better than peer group: -1,352.7% - ROE
-
104.5% Much better than peer group: -542.3% - ROA
-
91.4% Much better than peer group: -97.0% - Asset turnover
-
1.8% Much worse than peer group: 44.6% - FCF margin
-
-2,214.9% Much worse than peer group: -1,086.8% - FCF yield
-35.1% - Efficiency ratio
3,295.2% - Net sales per employee
-
€92.43K - Net income per employee
-
€4.70M